Feasibility of integrating residential care pharmacists into aged care homes to improve quality use of medicines: Study protocol for a non-randomised controlled pilot trial

Research output: Contribution to journalArticle

5 Citations (Scopus)
1 Downloads (Pure)

Abstract

Older adults are particularly susceptible to iatrogenic disease and communicable diseases, such as influenza. Prescribing in the residential aged care population is complex, and requires ongoing review to prevent medication misadventure. Pharmacist-led medication review is effective in reducing medication-related problems; however, current funding arrangements specifically exclude pharmacists from routinely participating in resident care. Integrating an on-site clinical pharmacist into residential care teams is an unexplored opportunity to improve quality use of medicines in this setting. The primary objective of this pilot study is to investigate the feasibility of integrating a residential care pharmacist into the existing care team. Secondary outcomes include incidence of pharmacist-led medication review, and incidence of potential medication problems based on validated prescribing measures. This is a cross-sectional, non-randomised controlled trial with a residential care pharmacist trialled at a single facility, and a parallel control site receiving usual care and services only. The results of this hypothesis-generating pilot study will be used to identify clinical outcomes and direct future larger scale investigations into the implementation of the novel residential care pharmacist model to optimise quality use of medicines in a population at high risk of medication misadventure.

Original languageEnglish
Article number499
Pages (from-to)1-14
Number of pages14
JournalInternational Journal of Environmental Research and Public Health
Volume15
Issue number3
DOIs
Publication statusPublished - 12 Mar 2018

Fingerprint

Homes for the Aged
Home Care Services
Pharmacists
Iatrogenic Disease
Incidence
Non-Randomized Controlled Trials
Human Influenza
Communicable Diseases

Cite this

@article{fb9f6e3fd4fc4c87b9c818e066897b64,
title = "Feasibility of integrating residential care pharmacists into aged care homes to improve quality use of medicines: Study protocol for a non-randomised controlled pilot trial",
abstract = "Older adults are particularly susceptible to iatrogenic disease and communicable diseases, such as influenza. Prescribing in the residential aged care population is complex, and requires ongoing review to prevent medication misadventure. Pharmacist-led medication review is effective in reducing medication-related problems; however, current funding arrangements specifically exclude pharmacists from routinely participating in resident care. Integrating an on-site clinical pharmacist into residential care teams is an unexplored opportunity to improve quality use of medicines in this setting. The primary objective of this pilot study is to investigate the feasibility of integrating a residential care pharmacist into the existing care team. Secondary outcomes include incidence of pharmacist-led medication review, and incidence of potential medication problems based on validated prescribing measures. This is a cross-sectional, non-randomised controlled trial with a residential care pharmacist trialled at a single facility, and a parallel control site receiving usual care and services only. The results of this hypothesis-generating pilot study will be used to identify clinical outcomes and direct future larger scale investigations into the implementation of the novel residential care pharmacist model to optimise quality use of medicines in a population at high risk of medication misadventure.",
keywords = "Dosage form modification, Influenza vaccination, Medication review, Pharmacist, Residential care",
author = "Nicole McDerby and Mark Naunton and Alison Shield and Kasia Bail and Sam Kosari",
year = "2018",
month = "3",
day = "12",
doi = "10.3390/ijerph15030499",
language = "English",
volume = "15",
pages = "1--14",
journal = "International Journal of Environmental Research and Public Health",
issn = "1660-4601",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

TY - JOUR

T1 - Feasibility of integrating residential care pharmacists into aged care homes to improve quality use of medicines: Study protocol for a non-randomised controlled pilot trial

AU - McDerby, Nicole

AU - Naunton, Mark

AU - Shield, Alison

AU - Bail, Kasia

AU - Kosari, Sam

PY - 2018/3/12

Y1 - 2018/3/12

N2 - Older adults are particularly susceptible to iatrogenic disease and communicable diseases, such as influenza. Prescribing in the residential aged care population is complex, and requires ongoing review to prevent medication misadventure. Pharmacist-led medication review is effective in reducing medication-related problems; however, current funding arrangements specifically exclude pharmacists from routinely participating in resident care. Integrating an on-site clinical pharmacist into residential care teams is an unexplored opportunity to improve quality use of medicines in this setting. The primary objective of this pilot study is to investigate the feasibility of integrating a residential care pharmacist into the existing care team. Secondary outcomes include incidence of pharmacist-led medication review, and incidence of potential medication problems based on validated prescribing measures. This is a cross-sectional, non-randomised controlled trial with a residential care pharmacist trialled at a single facility, and a parallel control site receiving usual care and services only. The results of this hypothesis-generating pilot study will be used to identify clinical outcomes and direct future larger scale investigations into the implementation of the novel residential care pharmacist model to optimise quality use of medicines in a population at high risk of medication misadventure.

AB - Older adults are particularly susceptible to iatrogenic disease and communicable diseases, such as influenza. Prescribing in the residential aged care population is complex, and requires ongoing review to prevent medication misadventure. Pharmacist-led medication review is effective in reducing medication-related problems; however, current funding arrangements specifically exclude pharmacists from routinely participating in resident care. Integrating an on-site clinical pharmacist into residential care teams is an unexplored opportunity to improve quality use of medicines in this setting. The primary objective of this pilot study is to investigate the feasibility of integrating a residential care pharmacist into the existing care team. Secondary outcomes include incidence of pharmacist-led medication review, and incidence of potential medication problems based on validated prescribing measures. This is a cross-sectional, non-randomised controlled trial with a residential care pharmacist trialled at a single facility, and a parallel control site receiving usual care and services only. The results of this hypothesis-generating pilot study will be used to identify clinical outcomes and direct future larger scale investigations into the implementation of the novel residential care pharmacist model to optimise quality use of medicines in a population at high risk of medication misadventure.

KW - Dosage form modification

KW - Influenza vaccination

KW - Medication review

KW - Pharmacist

KW - Residential care

UR - http://www.scopus.com/inward/record.url?scp=85044062063&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/feasibility-integrating-residential-care-pharmacists-aged-care-homes-improve-quality-medicines-study

U2 - 10.3390/ijerph15030499

DO - 10.3390/ijerph15030499

M3 - Article

VL - 15

SP - 1

EP - 14

JO - International Journal of Environmental Research and Public Health

JF - International Journal of Environmental Research and Public Health

SN - 1660-4601

IS - 3

M1 - 499

ER -